JAVIER IGNACIO
MUÑOZ GONZÁLEZ
Researcher in the period 2015-2019
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublications in collaboration with researchers from Instituto de Investigación Biomédica de Salamanca (11)
2024
-
Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 711-723
2022
-
Altered innate immune profile in blood of systemic mastocytosis patients
Clinical and Translational Allergy, Vol. 12, Núm. 6
-
Frequency and prognostic impact of blood-circulating tumor mast cells in mastocytosis
Blood, Vol. 139, Núm. 4, pp. 572-583
2021
-
Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosis
American Journal of Human Genetics, Vol. 108, Núm. 2, pp. 284-294
-
Pathogenic and diagnostic relevance of KIT in primary mast cell activation disorders
Annals of Allergy, Asthma and Immunology, Vol. 127, Núm. 4, pp. 427-434
-
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
The Lancet Haematology, Vol. 8, Núm. 3, pp. e194-e204
2019
-
Bone marrow mast cell antibody-targetable cell surface protein expression profiles in systemic mastocytosis
International Journal of Molecular Sciences, Vol. 20, Núm. 3
-
Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis
Blood, Vol. 134, Núm. 5, pp. 456-468
-
Mars: Mutation-adjusted risk score for advanced systemic mastocytosis
Journal of Clinical Oncology, Vol. 37, Núm. 31, pp. 2846-2856
2018
-
Characterization of CD34 + hematopoietic cells in systemic mastocytosis: Potential role in disease dissemination
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 6, pp. 1294-1304
-
Impact of somatic and germline mutations on the outcome of systemic mastocytosis
Blood Advances, Vol. 2, Núm. 21, pp. 2814-2828